HLSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,770 KRW | -1.22% |
|
+1.03% | -13.61% |
| Sales 2022 | 52.76B 38.72M 3.23B | Sales 2023 | 25.59B 18.78M 1.57B | Capitalization | 81.18B 59.59M 4.97B |
|---|---|---|---|---|---|
| Net income 2022 | 1.59B 1.17M 97.44M | Net income 2023 | -1.38B -1.01M -84.22M | EV / Sales 2022 | 1.29 x |
| Net cash position 2022 | 29.34B 21.53M 1.8B | Net cash position 2023 | 28.62B 21M 1.75B | EV / Sales 2023 | 2.05 x |
| P/E ratio 2022 |
61.2
x | P/E ratio 2023 |
-59
x | Employees | 76 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 31.2% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.22% | ||
| 1 week | +1.03% | ||
| Current month | -10.06% | ||
| 1 month | -10.06% | ||
| 3 months | -10.06% | ||
| 6 months | +11.05% | ||
| Current year | -13.61% |
1 week
13 560.00
14 070.00
1 month
13 050.0015 500.00
Current year
13 050.0018 200.00
1 year
11 300.0022 800.00
3 years
11 300.0043 500.00
5 years
11 300.00113 904.76
10 years
11 300.00113 904.76
| Managers | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 28/00/28 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 01/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hae-Yeon Lee
CEO | Chief Executive Officer | 55 | 28/00/28 |
Dong-Ryul Lee
BRD | Director/Board Member | 45 | 01/05/01 |
Dong-Wu Choi
BRD | Director/Board Member | 46 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 13,950 | +1.31% | 786 |
| 30/24/30 | 13,770 | -1.22% | 2,667 |
| 29/24/29 | 13,940 | +0.36% | 1,730 |
| 26/24/26 | 13,890 | +0.73% | 2,935 |
| 25/24/25 | 13,790 | -0.72% | 1,751 |
End-of-day quote Korea S.E., April 30, 2024
More quotes
HLscience Co., Ltd. is a Korea-based company primarily engaged in development, manufacture and distribution of healthcare products. The company manufactures products in the areas of live health, climacteric women health, stomach health, antioxidant/skin health, immunity, blood circulation improvement, eye health, intestinal health, articulation health, fatigue/stamina, diet, antioxidant/immunity, multi-vitamin/mineral/calcium, male health and general foods. The Company distributes its productions within domestic market and to overseas markets.
Sector
Food Processing
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.61% | 51.85M | |
| +13.21% | 8.15B | |
| -0.47% | 7.49B | |
| +12.30% | 6.65B | |
| -6.99% | 3.72B | |
| -6.49% | 3.7B | |
| -4.78% | 1.31B | |
| +12.61% | 972M | |
| -12.13% | 906M | |
| -38.53% | 938M |
- Stock Market
- Equities
- A239610 Stock
